Viewing Study NCT02214004


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2026-01-24 @ 7:08 AM
Study NCT ID: NCT02214004
Status: UNKNOWN
Last Update Posted: 2018-02-15
First Post: 2014-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women
Sponsor: Gangnam Severance Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast cancer View
None HER2 View
None ER View
None Postmenopausal View
None Trastuzumab View
None Letrozole View
None Neoadjuvant endocrine treatment View